Status update: February 18, 2010
Number of sites enrolling: 9 |
|
| Studies using samples (see details) |
| Studies complete: | 6 (BWH, OMRF, St. John's [data], SUNY[B.Kalman], Vanderbilt,
Wellcome Trust) |
| Studies ongoing: | 23 (BIDMC, Diogenix[2], Glycominds, HSPH,
Johns Hopkins, Mayo Clinic, Montreal Neurological
Institute, MSDx[2], NASA, Pfizer, Protagen, Science
Commons [data], Scripps Research Institute,
St. Vincent's Hospital, Stanford, SUNY[P.Massa], UCI, UCSF,
UMaryland[data], UTSW[2: O.Stuve, B.Greenberg[data]]) |
| Studies approved: | 1 |
| Studies pending: | 0 |
|
